Aug. 7 (UPI) --A new test for gonorrhea can determine whether those infected will respond successfully to the inexpensive oral antibiotic ciprofloxacin, according to a study published Friday by ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Gonorrhea is the second most common notifiable disease ...

For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection is ...

Background and Goal: Prompt treatment of chlamydia and gonorrhea following a confirmed diagnosis is essential to prevent complications and reduce transmission. Adherence to the Centers for Disease ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections in decades, and the first developed as part of a public-private ...

The patients recovered, but the bacteria was resistant to several antibiotics. Gonorrhea is the second most common STI in the US — and it's on the rise. Health officials are on alert since a new ...

The FDA approved gepotidacin (Blujepa), an oral option for the treatment of uncomplicated urogenital gonorrhea among patients ages 12 years and older, GSK announced on Thursday.

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (NEXSTAR) – Medical researchers in Europe ...

(NEXSTAR) – Medical researchers in Europe say a strain of so-called “super gonorrhea” was recently detected in a patient who returned from a trip to Cambodia in April. The 50-year-old male patient, ...